Gemer Forte 1 Tablet PR is a combination oral antihyperglycemic agent containing Glimepiride (1mg) and Metformin (850mg), indicated for the management of type 2 diabetes mellitus. Glimepiride, a sulfonylurea, stimulates pancreatic beta cells to release insulin, thereby reducing blood glucose levels. Metformin, a biguanide, primarily decreases hepatic glucose production and improves insulin sensitivity in peripheral tissues, contributing to enhanced glycemic control. This dual-action formulation is designed to address both insulin secretion deficits and insulin resistance, common pathophysiological features in type 2 diabetes. Gemer Forte 1 Tablet PR is typically prescribed when diet, exercise, and monotherapy with either agent alone do not provide adequate glycemic control. The extended-release formulation allows for once-daily dosing, improving patient compliance. It is essential to monitor blood glucose levels regularly and adjust dosage based on therapeutic response and tolerability. Common side effects may include gastrointestinal disturbances such as nausea, diarrhea, and abdominal discomfort, which often subside with continued use. Caution is advised in patients with renal impairment, hepatic dysfunction, or conditions predisposing to lactic acidosis. Gemer Forte 1 Tablet PR should be used under medical supervision, with periodic assessment of renal function and blood glucose to optimize treatment outcomes.